糖尿病合并脑梗死患者急性期血清IL-18、MMP-7和MMP-8水平的变化及阿托伐他汀调脂治疗的干预作用

被引:9
作者
许莹
王亚萍
曾庆岭
机构
[1] 武汉市第五医院内分泌科
关键词
脑梗死; 2型糖尿病; 阿托伐他汀; 白细胞介素-18; 基质金属蛋白酶; 动脉粥样硬化;
D O I
暂无
中图分类号
R587.1 [糖尿病]; R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ; 100201 ;
摘要
目的观察糖尿病合并脑梗死患者急性期血清炎性因子白细胞介素-18(IL-18)、基质金属蛋白酶-7(MMP-7)及基质金属蛋白酶-8(MMP-8)水平的变化和临床意义,探讨不同剂量阿托伐他汀调脂治疗对脑梗死炎症抑制和颈动脉斑块稳定性的作用。方法 120例糖尿病合并脑梗死患者根据颈动脉超声检查结果分为颈动脉稳定斑块组(n=60)和颈动脉易损斑块组(n=60),抽血检查后分别随机分为小剂量组30例(阿托伐他汀10 mg/d,口服)和大剂量组30例(阿托伐他汀40 mg/d,口服)。比较治疗前和治疗后4周血清IL-18、MMP-7和MMP-8水平的变化。结果治疗前,同种性质斑块组中两亚组间(大、小剂量组)血清IL-18、MMP-7和MMP-8水平差异均无统计学意义(均P>0.05),两种性质斑块间比较,易损斑块组中亚组无论是小剂量组或大剂量组血清IL-18、MMP-7和MMP-8水平均高于稳定斑块组(均P<0.01)。治疗后4周,同一性质斑块组中亚组(大、小剂量组)血清IL-18、MMP-7和MMP-8水平均下降,但大剂量组三项指标下降幅度均大于小剂量组(均P<0.01)。结论血清IL-18、MMP-7和MMP-8水平均可能作为糖尿病合并脑梗死患者颈动脉易损斑块检测的生物学指标,大剂量阿托伐他汀调脂治疗能迅速降低患者血清炎性因子水平,在一定程度上可提高易损斑块的稳定性。
引用
收藏
页码:10 / 12+15 +15
页数:4
相关论文
共 4 条
[1]  
Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study[J] . Danielle Ní Chróinín,Elizabeth L. Callaly,Joseph Duggan,áine Merwick,Niamh Hannon,órla Sheehan,Michael Marnane,Gillian Horgan,Emma B. Williams,Dawn Harris,Lorraine Kyne,Patricia M.E. McCormack,Joan Moroney,Tim Grant,David Williams,Leslie Daly,Peter J. Kelly. Stroke . 2011 (4)
[2]  
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . Karen L. Furie,Scott E. Kasner,Robert J. Adams,Gregory W. Albers,Ruth L. Bush,Susan C. Fagan,Jonathan L. Halperin,S. Claiborne Johnston,Irene Katzan,Walter N. Kernan,Pamela H. Mitchell,Bruce Ovbiagele,Yuko Y. Palesch,Ralph L. Sacco,Lee H. Schwamm,Sylvia Wassertheil-Smoller,Tanya N. Turan,D
[3]  
Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications[J] . Ronald B. Goldberg. The Journal of Clinical Endocrinology & Metabolism . 2009 (9)
[4]  
Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed[J] . Atherosclerosis . 2003 (2)